Core Team
Started and led by a tech entrepreneur who personally suffers from life threatening food allergies, we have a diverse team with collective backgrounds in design, mechanical engineering, mobile app development, medical technology and business development.

Javier Evelyn

Lisa Lombard, Ph.D

Yue Wang
Ken Johnson
Core Team
Our team has exited founders with experience bringing FDA cleared medical devices to market and developing software at the intersection of health and technology. Alerje brings a unique blend of expertise in device development, behavioral health, sales, software engineering, and healthcare systems, including prior work with PBMs and insurance companies. We’re focused on building tech-enabled solutions that reduce anxiety and improve daily life for people managing food allergies.

Javier Evelyn
Founder & CEO

Ryan Leard
VP of Engineering & Regulatory

Lisa Lombard, PhD
Clinical Psychologist

Solomon Ssenyange, PhD
Global Strategic Advisor
Board of Directors
Alerje’s board brings together expertise in medtech M&A, device and software commercialization, cross-border partnerships with Japanese corporations, strategic investing, and brand building, anchored by lived experience in food allergy and a track record of launching and scaling impactful digital health ventures.

Javier Evelyn

Solomon Ssenyange, PhD

Jeff Ponders, II
Our Scientific Advisory Board
Alerje's Scientifc Advisory Board represents some of the brightest medical minds in the industry. They're also deeply committed to looking at ways to improve the lives of families managing food allergies.

Dr. Quindelyn Cook, M.D.

Dr. Malika Gupta, M.D.

Dr. Phillip D. Levy, M.D., M.P.H.

Dr. Robert Moskowitz, M.D.

Dr. Jonathan Tam

Dr. Niti Chokshi, M.D.

Dr. Sofija Volertas

Dr. Stacy Silvers
Our Advisory Board
We have veteran advisors with backgrounds in big pharma, medtech, data, IoT, and clinical industry expertise that have allowed us to learn fast. One of our advisors has built and scaled multiple healthcare companies that resulted in successful exits to strategic buyers.

Frank Orlowski

David Esposito

Dr. Sabine Seymour

Brian Kastenholz
Investors
Our innovation would not be possible with the support of investors seeking to make a difference in communities everywhere. We appreciate the support of the following group of investors.
